MusclePharm Corporation Restructuring Costs
MusclePharm Corporation reported Restructuring Costs of $310.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2018-11-14
- MusclePharm Corporation restructuring costs for the quarter ending 2018-09-30 was $109.00K.
- MusclePharm Corporation restructuring costs for the quarter ending 2017-12-31 was $0.00.
- MusclePharm Corporation restructuring costs for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- MusclePharm Corporation restructuring costs for the quarter ending 2017-06-30 was $0.00.
- MusclePharm Corporation restructuring costs for fiscal 2017 was $0.00.
- MusclePharm Corporation restructuring costs for fiscal 2016 was -$3.48M, a 119.01% decline from fiscal 2015.
- MusclePharm Corporation restructuring costs for fiscal 2015 was $18.29M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2018-09-30 | $109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $310.00K 10-Q · filed 2018-11-14 | ||
| 2018-06-30 | $201.00K 10-Q · filed 2018-08-14 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $0.00 derived: sum of 3 quarters · filed 2018-04-02 | $0.00 10-K · filed 2018-04-02 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | -$898.00K derived: sum of 4 quarters · filed 2018-04-02 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | -$898.00K derived: sum of 3 quarters · filed 2018-04-02 | $769.00K derived: sum of 4 quarters · filed 2018-04-02 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-12 | -$898.00K derived: sum of 2 quarters · filed 2018-04-02 | $769.00K derived: sum of 3 quarters · filed 2018-04-02 | -$4.05M derived: sum of 4 quarters · filed 2018-04-02 |
| 2016-12-31 | -$898.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $769.00K derived: sum of 2 quarters · filed 2018-04-02 | -$4.05M derived: sum of 3 quarters · filed 2018-04-02 | -$3.48M 10-K · filed 2018-04-02 |
| 2016-09-30 | $1.67M 10-Q · filed 2017-11-14 | -$3.15M derived: sum of 2 quarters · filed 2017-11-14 | -$2.58M 10-Q · filed 2017-11-14 | -$936.00K derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | -$4.82M 10-Q · filed 2017-08-14 | -$4.25M 10-Q · filed 2017-08-14 | -$2.60M derived: sum of 3 quarters · filed 2017-08-14 | $14.05M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $574.00K 10-Q · filed 2017-05-12 | $2.22M derived: sum of 2 quarters · filed 2017-05-12 | $18.87M derived: sum of 3 quarters · filed 2017-05-12 | |
| 2015-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $18.29M derived: sum of 2 quarters · filed 2017-03-15 | $18.29M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $16.65M 10-Q · filed 2016-11-09 | $16.65M 10-Q · filed 2016-11-09 |